Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06533254 · ClinicalTrials.gov registry record
Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake
A clinical trial of Chronic Kidney Disease, sponsored by Scaled Insights.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT06533254 is a study of Chronic Kidney Disease that is actively recruiting participants, run by Scaled Insights. The registered enrollment target is 3,000 participants, roughly in line with the 3,177-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06533254, a study of Chronic Kidney Disease, is actively recruiting participants, sponsored by Scaled Insights.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Scaled Insights Behavioral AI will be used to improve clinicians ability to detect and understand: The likelihood of patients with kidney failure opting for peritoneal dialysis and to select the right personalized nudge to get CKD patients to choose peritoneal dialysis Scaled Insights' can utilize the data from this study to develop individualized nudges for healthcare professionals that can be broadly deployed within a digital platform so that clinics across the English speaking world can use it as a means of supporting patients with CKD in selecting peritoneal dialysis treatment. Using Scaled Insights novel Behavioral Artificial Intelligence solution, the proposed project has two aims: 1. to identify personality attributes of patients with Chronic Kidney Disease and correlating their personality attributes with their subsequent choice of dialysis. Once correlated into personality based clusters, the AI Model will then be able will determine which personality cluster each net new patient will fall into and therefore predict their specific likelihood of opting for peritoneal dialysis or hemodialysis 2. once prediction is possible, customized nudges towards the selection of PD will be developed and tested to improve the likelihood that patients will opt for peritoneal dialysis Hypotheses: 1. Scaled Insights Behavioral AI will identify the personality characteristics of patients with Chronic Kidney Disease who are likely to opt for both peritoneal dialysis and hemodialysis (Phase 1) 2. Scaled Insights Behavioral AI will identify the nudges that are most effective in encouraging or supporting patients with Chronic Kidney Disease in choosing peritoneal dialysis over hemodialysis (Phase 2)
Conditions Studied
Interventions
- OTHER Predicting choice of dialysis
- BEHAVIORAL Behavioral nudges
Study Locations (1)
Texas
- Dallas Renal Group - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06533254
The ClinicalTrials.gov registry entry for NCT06533254 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 3,177-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target. The listed sponsor is Scaled Insights, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 2 interventions - of which Predicting choice of dialysis is the first listed.
NCT06533254 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06533254 about?
NCT06533254 is a clinical study titled "Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake". Scaled Insights Behavioral AI will be used to improve clinicians ability to detect and understand: The likelihood of patients with kidney failure opting for peritoneal dialysis and to select the right personalized nudge to get CKD patients to choose peritoneal dialysis Scaled Insights' can utilize ...
What is the current status of trial NCT06533254?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2024-09-01. Estimated completion is 2025-12-31.
What conditions does trial NCT06533254 study?
This clinical trial studies the following conditions: Chronic Kidney Disease.
What interventions are being tested in trial NCT06533254?
The interventions under investigation include: Predicting choice of dialysis (OTHER), Behavioral nudges (BEHAVIORAL).
Who is sponsoring clinical trial NCT06533254?
This trial is sponsored by Scaled Insights, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06533254 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
RECRUITING · Phase 2
-
Patient-driven Management of BP in CKD
RECRUITING · Phase 3
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Safety of Short-course of NSAIDs in Pediatric Patients With CKD
RECRUITING · Phase 4
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.